A unique de novo gain-of-function variant in CAMK4 associated with intellectual disability and hyperkinetic movement disorder

Calcium/calmodulin-dependent protein kinases (CaMKs) are key mediators of calcium signaling and underpin neuronal health. Although widely studied, the contribution of CaMKs to Mendelian disease is rather enigmatic. Here, we describe an unusual neurodevelopmental phenotype, characterized by milestone delay, intellectual disability, autism, ataxia, and mixed hyperkinetic movement disorder including severe generalized dystonia, in a proband who remained etiologically undiagnosed despite exhaustive testing. We performed trio whole-exome sequencing to identify a de novo essential splice-site variant (c.981+1G>A) in CAMK4, encoding CaMKIV. Through in silico evaluation and cDNA analyses, we demonstrated that c.981+1G>A alters CAMK4 pre-mRNA processing and results in a stable mRNA transcript containing a 77-nt out-of-frame deletion and a premature termination codon within the last exon. The expected protein, p.Lys303Serfs*28, exhibits selective loss of the carboxy-terminal regulatory domain of CaMKIV and bears striking structural resemblance to previously reported synthetic mutants that confer constitutive CaMKIV activity. Biochemical studies in proband-derived cells confirmed an activating effect of c.981+1G>A and indicated that variant-induced excessive CaMKIV signaling is sensitive to pharmacological manipulation. Additionally, we found that variants predicted to cause selective depletion of CaMKIV's regulatory domain are unobserved in diverse catalogs of human variation, thus revealing that c.981+1G>A is a unique molecular event. We propose that our proband's phenotype is explainable by a dominant CAMK4 splice-disrupting mutation that acts through a gain-of-function mechanism. Our findings highlight the importance of CAMK4 in human neurodevelopment, provide a foundation for future clinical research of CAMK4, and suggest the CaMKIV signaling pathway as a potential drug target in neurological disease.

[1]  R. Rodriguiz,et al.  Cerebellar Defects in Ca2+/Calmodulin Kinase IV-Deficient Mice , 2000, The Journal of Neuroscience.

[2]  K. Jensen,et al.  Ca2+/calmodulin-dependent protein kinase enriched in cerebellar granule cells. Identification of a novel neuronal calmodulin-dependent protein kinase. , 1989, The Journal of biological chemistry.

[3]  D. Schomburg,et al.  Ca 2+ /calmodulin-dependent protein kinase , 1997 .

[4]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[5]  A. Edelman,et al.  Ca(2+)-calmodulin-dependent protein kinases Ia and Ib from rat brain. II. Enzymatic characteristics and regulation of activities by phosphorylation and dephosphorylation. , 1992, The Journal of biological chemistry.

[6]  A. Means,et al.  Activation of orphan receptor‐mediated transcription by Ca2+/calmodulin‐dependent protein kinase IV , 2000, The EMBO journal.

[7]  F. Ahmad,et al.  Calcium/calmodulin-dependent protein kinase IV: A multifunctional enzyme and potential therapeutic target. , 2016, Progress in biophysics and molecular biology.

[8]  Tomas W. Fitzgerald,et al.  Large-scale discovery of novel genetic causes of developmental disorders , 2014, Nature.

[9]  Raphael A. Bernier,et al.  denovo-db: a compendium of human de novo variants , 2016, Nucleic Acids Res..

[10]  D. Black,et al.  A consensus CaMK IV-responsive RNA sequence mediates regulation of alternative exons in neurons. , 2005, RNA.

[11]  M. Wilson,et al.  An Important Role of Neural Activity-Dependent CaMKIV Signaling in the Consolidation of Long-Term Memory , 2001, Cell.

[12]  R.,et al.  Biochemical Characterization of the Multifunctional Ca 2 + / Calmodulin-dependent Protein Kinase Type IV Expressed in Insect Cells * , 2001 .

[13]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[14]  R. Nicoll,et al.  Single-Cell Optogenetic Excitation Drives Homeostatic Synaptic Depression , 2010, Neuron.

[15]  A. Means,et al.  Biochemical characterization of the multifunctional Ca2+/calmodulin-dependent protein kinase type IV expressed in insect cells. , 1993, Journal of Biological Chemistry.

[16]  Stephan J Sanders,et al.  Dual Molecular Effects of Dominant RORA Mutations Cause Two Variants of Syndromic Intellectual Disability with Either Autism or Cerebellar Ataxia. , 2018, American journal of human genetics.

[17]  M. Zhuo,et al.  Calcium–calmodulin-dependent protein kinase IV is required for fear memory , 2002, Nature Neuroscience.

[18]  A. Means,et al.  A Unique Phosphorylation-dependent Mechanism for the Activation of Ca2+/Calmodulin-dependent Protein Kinase Type IV/GR* , 1996, The Journal of Biological Chemistry.

[19]  R. Bassel-Duby,et al.  Regulation of Mitochondrial Biogenesis in Skeletal Muscle by CaMK , 2002, Science.

[20]  H. Jinnah,et al.  Evolving concepts in the pathogenesis of dystonia. , 2018, Parkinsonism & related disorders.

[21]  H. Enslen,et al.  Differential activation of CREB by Ca2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity. , 1994, Genes & development.

[22]  K. Deisseroth,et al.  CREB Phosphorylation and Dephosphorylation: A Ca2+- and Stimulus Duration–Dependent Switch for Hippocampal Gene Expression , 1996, Cell.

[23]  James Y. Zou Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[24]  C. Gieger,et al.  Recessive mutations in the α3 (VI) collagen gene COL6A3 cause early-onset isolated dystonia. , 2015, American journal of human genetics.

[25]  H. Tokumitsu,et al.  STO-609, a Specific Inhibitor of the Ca2+/Calmodulin-dependent Protein Kinase Kinase* , 2002, The Journal of Biological Chemistry.

[26]  F. Sato,et al.  An immunohistochemical study of Ca2+/calmodulin-dependent protein kinase IV in the rat central nervous system: Light and electron microscopic observations , 1995, Neuroscience.

[27]  H. Bito,et al.  Calmodulin kinases: essential regulators in health and disease , 2017, Journal of neurochemistry.

[28]  Douglas L Black,et al.  Depolarization and CaM Kinase IV Modulate NMDA Receptor Splicing through Two Essential RNA Elements , 2007, PLoS biology.

[29]  A. Means,et al.  Regulation and Function of the Calcium/Calmodulin-dependent Protein Kinase IV/Protein Serine/Threonine Phosphatase 2A Signaling Complex* , 2004, Journal of Biological Chemistry.

[30]  Gina G. Turrigiano,et al.  All for One But Not One for All: Excitatory Synaptic Scaling and Intrinsic Excitability Are Coregulated by CaMKIV, Whereas Inhibitory Synaptic Scaling Is Under Independent Control , 2017, The Journal of Neuroscience.

[31]  P. Calabresi,et al.  Hyperkinetic disorders and loss of synaptic downscaling , 2016, Nature Neuroscience.

[32]  Hilmar Bading,et al.  Nuclear calcium signalling in the regulation of brain function , 2013, Nature Reviews Neuroscience.

[33]  T. Wieland,et al.  Clinical exome sequencing in early‐onset generalized dystonia and large‐scale resequencing follow‐up , 2017, Movement disorders : official journal of the Movement Disorder Society.

[34]  D. Srivastava,et al.  Convergent CaMK and RacGEF signals control dendritic structure and function. , 2008, Trends in cell biology.

[35]  Andrew J. Hill,et al.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, bioRxiv.

[36]  W. Poewe,et al.  Haploinsufficiency of KMT2B, Encoding the Lysine-Specific Histone Methyltransferase 2B, Results in Early-Onset Generalized Dystonia. , 2016, American journal of human genetics.

[37]  Wade Morishita,et al.  Generation of Silent Synapses by Acute In Vivo Expression of CaMKIV and CREB , 2005, Neuron.

[38]  Silvio Alessandro Di Gioia,et al.  DOMINO: Using Machine Learning to Predict Genes Associated with Dominant Disorders. , 2017, American journal of human genetics.

[39]  B. V. van Bon,et al.  DVL1 frameshift mutations clustering in the penultimate exon cause autosomal-dominant Robinow syndrome. , 2015, American journal of human genetics.

[40]  F. Supek,et al.  The rules and impact of nonsense-mediated mRNA decay in human cancers , 2016, Nature Genetics.

[41]  古塚 大介,et al.  ペンチレンテトラゾール誘発痙攣によるマウス脳Ca^ /calmodulin dependent protein kinase II活性の変化 , 1996 .

[42]  T. Soderling,et al.  Calcium/calmodulin-dependent protein kinase kinase: identification of regulatory domains. , 1997, Biochemistry.

[43]  M. Waxham,et al.  Ca2+/Calmodulin-dependent Protein Kinases , 2008, Cellular and Molecular Life Sciences.

[44]  R. Fisher,et al.  Nuclear and axonal localization of Ca2+/calmodulin-dependent protein kinase type Gr in rat cerebellar cortex. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[45]  K. Lohmann,et al.  Update on the Genetics of Dystonia , 2017, Current Neurology and Neuroscience Reports.

[46]  Nicholas C Spitzer,et al.  Calcium signaling in neuronal development. , 2011, Cold Spring Harbor perspectives in biology.

[47]  Gabriele Gillessen-Kaesbach,et al.  Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome. , 2012, American journal of human genetics.

[48]  J. Rosenfeld,et al.  A Recurrent De Novo Nonsense Variant in ZSWIM6 Results in Severe Intellectual Disability without Frontonasal or Limb Malformations. , 2017, American journal of human genetics.

[49]  Allan Jacobson,et al.  NMD: a multifaceted response to premature translational termination , 2012, Nature Reviews Molecular Cell Biology.

[50]  V. Sée,et al.  Calcium/calmodulin‐dependent protein kinase type IV (CaMKIV) inhibits apoptosis induced by potassium deprivation in cerebellar granule neurons , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  D. Black,et al.  A CaMK IV responsive RNA element mediates depolarization-induced alternative splicing of ion channels , 2001, Nature.

[52]  S. Robertson,et al.  Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss , 2011, Nature Genetics.

[53]  Meghan C Towne,et al.  De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability. , 2017, American journal of human genetics.

[54]  L. Vissers,et al.  De Novo Truncating Mutations in the Last and Penultimate Exons of PPM1D Cause an Intellectual Disability Syndrome. , 2017, American journal of human genetics.

[55]  Allan R. Jones,et al.  Genome-wide atlas of gene expression in the adult mouse brain , 2007, Nature.

[56]  N. Mencacci,et al.  Emerging Monogenic Complex Hyperkinetic Disorders , 2017, Current Neurology and Neuroscience Reports.

[57]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[58]  A. Means,et al.  Defining Ca2+/Calmodulin-dependent Protein Kinase Cascades in Transcriptional Regulation* , 2001, The Journal of Biological Chemistry.